Otonomy (NASDAQ:OTIC) Research Coverage Started at StockNews.com
Research analysts at StockNews.com started coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research report issued to clients and investors on Monday. The firm set a "hold" rating on the
Otonomy (NASDAQ:OTIC) Earns Hold Rating From Analysts at StockNews.com
StockNews.com began coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research report sent to investors on Thursday. The firm issued a hold rating on the biopharmaceutical company's stock.
Spiral Therapeutics Acquires Otonomy Assets to Boost Inner Ear Disorders Pipeline and Appoints Industry Leaders to Board
Spiral Therapeutics acquires assets from Otonomy, including data, patent rights, and inventory related to OTO-104, OTO-510, and OTO-413 Clinical data analysis suggests Spiral's lead candidate, SPT-21
Olema Pharmaceuticals (NASDAQ:OLMA) and Otonomy (NASDAQ:OTIC) Critical Comparison
Olema Pharmaceuticals (NASDAQ:OLMA – Get Rating) and Otonomy (NASDAQ:OTIC – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based
Requisite Capital Management LLC Acquires Shares of 150,000 Otonomy, Inc. (NASDAQ:OTIC)
Requisite Capital Management LLC acquired a new stake in Otonomy, Inc. (NASDAQ:OTIC – Get Rating) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Ex
StockNews.com Initiates Coverage on Otonomy (NASDAQ:OTIC)
StockNews.com began coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research report sent to investors on Saturday morning. The firm issued a hold rating on the biopharmaceutical company'
Otonomy (NASDAQ:OTIC) Now Covered by StockNews.com
Analysts at StockNews.com began coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research report issued on Friday. The firm set a "hold" rating on the biopharmaceutical company's stock.
Otonomy (NASDAQ:OTIC) Stock Passes Below 200-Day Moving Average of $0.32
Otonomy, Inc. (NASDAQ:OTIC – Get Rating)'s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.32 and traded as low as $0.1
Otonomy (NASDAQ:OTIC) Receives New Coverage From Analysts at StockNews.com
Investment analysts at StockNews.com started coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research note issued on Thursday. The brokerage set a "hold" rating on the biopharmaceutical
Otonomy (NASDAQ:OTIC) & Bio-Path (NASDAQ:BPTH) Financial Comparison
Otonomy (NASDAQ:OTIC – Get Rating) and Bio-Path (NASDAQ:BPTH – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the streng
Otonomy (NASDAQ:OTIC) Share Price Crosses Above 50-Day Moving Average of $0.11
Otonomy, Inc. (NASDAQ:OTIC – Get Rating) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.11 and traded as high as $0.13. Otonomy shares
Head-To-Head Review: Bio-Path (NASDAQ:BPTH) Versus Otonomy (NASDAQ:OTIC)
Bio-Path (NASDAQ:BPTH – Get Rating) and Otonomy (NASDAQ:OTIC – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the streng
StockNews.com Begins Coverage on Otonomy (NASDAQ:OTIC)
Analysts at StockNews.com started coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research note issued to investors on Tuesday. The firm set a "hold" rating on the biopharmaceutical com
Otonomy (NASDAQ:OTIC) Coverage Initiated by Analysts at StockNews.com
Analysts at StockNews.com began coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research note issued to investors on Monday. The brokerage set a "hold" rating on the biopharmaceutical c
Elk Capital Makes Investment in Otonomy
Delisting of Securities of Tuscan Holdings Corp. II; Clovis Oncology, Inc.; ZyVersa Therapeutics, Inc.; Otonomy, Inc., and Forward Pharma A/S From The Nasdaq Stock Market
NEW YORK, Dec. 28, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock, unit, and warrant of Tuscan Holdings Corp. II. Tuscan Holdings Corp. II's securities were
Otonomy (NASDAQ:OTIC) Coverage Initiated at StockNews.com
StockNews.com initiated coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research report sent to investors on Saturday. The brokerage issued a hold rating on the biopharmaceutical compan
Otonomy (NASDAQ:OTIC) Earns Hold Rating From Analysts at StockNews.com
StockNews.com started coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research report sent to investors on Saturday morning. The firm issued a hold rating on the biopharmaceutical compa
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersImmuron (NASDAQ:IMRN) stock rose 42.9% to $2.3 during Monday's pre-market session. The market value of their outstanding shares is at $13.0 million. DBV Technologies (NASDAQ:DBVT) shares moved
Otonomy (NASDAQ:OTIC) Now Covered by Analysts at StockNews.com
Investment analysts at StockNews.com initiated coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a report issued on Saturday. The brokerage set a "hold" rating on the biopharmaceutical comp
No Data